AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. GH
  4. [Form 4] Guardant Health, Inc. Insider Trading Activity

[Form 4] Guardant Health, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Guardant Health Director Ian T. Clark reported multiple securities transactions on June 17-18, 2025:

  • Disposed of 6,672 shares of common stock at an average price of $48.38 per share from the Thornton-Clark Family Trust
  • Received a new stock option grant for 6,833 shares with exercise price of $50.57, vesting in full on June 18, 2025 or next annual stockholders meeting
  • Granted 5,092 restricted stock units (RSUs) vesting in full on June 18, 2025 or next annual stockholders meeting

Following these transactions, Clark retains 9,851 shares indirectly through the family trust, plus the new equity awards. The stock sale was executed in multiple transactions within a $0.03 price range.

Ian T. Clark, Direttore di Guardant Health, ha riportato diverse operazioni su titoli nei giorni 17-18 giugno 2025:

  • Ha ceduto 6.672 azioni ordinarie a un prezzo medio di $48,38 per azione, provenienti dal Thornton-Clark Family Trust
  • Ha ricevuto una nuova concessione di opzioni su azioni per 6.833 azioni con prezzo di esercizio di $50,57, che maturano completamente il 18 giugno 2025 o alla prossima assemblea annuale degli azionisti
  • Ha ottenuto 5.092 unit脿 azionarie vincolate (RSU) che maturano completamente il 18 giugno 2025 o alla prossima assemblea annuale degli azionisti

Dopo queste operazioni, Clark detiene indirettamente tramite il family trust 9.851 azioni, oltre ai nuovi premi azionari. La vendita delle azioni 猫 stata effettuata in pi霉 transazioni con una variazione di prezzo di $0,03.

Ian T. Clark, Director de Guardant Health, inform贸 m煤ltiples transacciones de valores los d铆as 17-18 de junio de 2025:

  • Dispuso de 6,672 acciones ordinarias a un precio promedio de $48.38 por acci贸n, provenientes del Thornton-Clark Family Trust
  • Recibi贸 una nueva concesi贸n de opciones sobre acciones por 6,833 acciones con un precio de ejercicio de $50.57, que se consolidan completamente el 18 de junio de 2025 o en la pr贸xima reuni贸n anual de accionistas
  • 翱迟辞谤驳贸 5,092 unidades de acciones restringidas (RSU) que se consolidan por completo el 18 de junio de 2025 o en la pr贸xima reuni贸n anual de accionistas

Tras estas transacciones, Clark mantiene 9,851 acciones indirectamente a trav茅s del fideicomiso familiar, adem谩s de las nuevas concesiones de capital. La venta de acciones se llev贸 a cabo en m煤ltiples transacciones dentro de un rango de precio de $0.03.

Guardant Health鞚� 鞚挫偓 Ian T. Clark臧� 2025雲� 6鞗� 17-18鞚检棎 鞐煬 歃濌秾 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟:

  • Thornton-Clark 臧�臁� 鞁犿儊鞚� 韱淀暣 氤挫湢頃� 氤错喌欤� 6,672欤�毳� 欤茧嫻 韽夑窢 $48.38鞐� 觳橂秳頃�
  • 頄夓偓臧赌瓴� $50.57鞚� 6,833欤�鞚� 鞁犼窚 鞀ろ啞鞓奠厴 攵赌鞐�, 2025雲� 6鞗� 18鞚� 霕愲姅 雼れ潓 鞐半 欤检＜齑濏殞鞐� 鞝勲秬 頄夓偓 臧�電�
  • 2025雲� 6鞗� 18鞚� 霕愲姅 雼れ潓 鞐半 欤检＜齑濏殞鞐� 鞝勲秬 旆摑霅橂姅 5,092 鞝滍暅 欤检嫕 雼渼(RSU) 攵赌鞐�

鞚� 瓯半灅霌� 鞚错泟 Clark鞚� 臧�臁� 鞁犿儊鞚� 韱淀暣 臧勳爲鞝侅溂搿� 9,851欤�毳� 氤挫湢頃橂┌, 鞁犼窚 欤检嫕 氤挫儊霃� 韽暔霅╇媹雼�. 欤检嫕 毵る弰電� $0.03 臧�瓴� 氩旍渼 雮� 鞐煬 瓯挫溂搿� 鞚措（鞏挫鞀惦媹雼�.

Ian T. Clark, directeur de Guardant Health, a d茅clar茅 plusieurs transactions sur titres les 17 et 18 juin 2025 :

  • A c茅d茅 6 672 actions ordinaires 脿 un prix moyen de 48,38 $ par action provenant du Thornton-Clark Family Trust
  • A re莽u une nouvelle attribution d'options d'achat portant sur 6 833 actions avec un prix d'exercice de 50,57 $, acquises en totalit茅 le 18 juin 2025 ou lors de la prochaine assembl茅e annuelle des actionnaires
  • A obtenu 5 092 unit茅s d'actions restreintes (RSU) acquises en totalit茅 le 18 juin 2025 ou lors de la prochaine assembl茅e annuelle des actionnaires

Apr猫s ces op茅rations, Clark d茅tient indirectement 9 851 actions via le family trust, en plus des nouvelles attributions d'actions. La vente des actions a 茅t茅 r茅alis茅e en plusieurs op茅rations dans une fourchette de prix de 0,03 $.

Ian T. Clark, Direktor von Guardant Health, meldete mehrere Wertpapiertransaktionen am 17. und 18. Juni 2025:

  • 痴别谤盲耻脽别谤迟别 6.672 Stammaktien zu einem Durchschnittspreis von 48,38 $ pro Aktie aus dem Thornton-Clark Family Trust
  • Erhielt eine neue Aktienoptionszuteilung f眉r 6.833 Aktien mit einem Aus眉bungspreis von 50,57 $, die vollst盲ndig am 18. Juni 2025 oder auf der n盲chsten j盲hrlichen Hauptversammlung der Aktion盲re f盲llig wird
  • Gew盲hrt wurden 5.092 Restricted Stock Units (RSUs), die ebenfalls am 18. Juni 2025 oder auf der n盲chsten j盲hrlichen Hauptversammlung vollst盲ndig freigegeben werden

Nach diesen Transaktionen h盲lt Clark indirekt 9.851 Aktien 眉ber den Family Trust sowie die neuen Aktienverg眉tungen. Der Aktienverkauf erfolgte in mehreren Transaktionen innerhalb einer Preisspanne von 0,03 $.

Positive
  • Director received new equity compensation with 6,833 stock options at $50.57 strike price and 5,092 RSUs, aligning long-term interests with shareholders
Negative
  • Director Ian Clark sold 6,672 shares at $48.38-$48.41 per share (approximately $323K total value) through family trust

Ian T. Clark, Direttore di Guardant Health, ha riportato diverse operazioni su titoli nei giorni 17-18 giugno 2025:

  • Ha ceduto 6.672 azioni ordinarie a un prezzo medio di $48,38 per azione, provenienti dal Thornton-Clark Family Trust
  • Ha ricevuto una nuova concessione di opzioni su azioni per 6.833 azioni con prezzo di esercizio di $50,57, che maturano completamente il 18 giugno 2025 o alla prossima assemblea annuale degli azionisti
  • Ha ottenuto 5.092 unit脿 azionarie vincolate (RSU) che maturano completamente il 18 giugno 2025 o alla prossima assemblea annuale degli azionisti

Dopo queste operazioni, Clark detiene indirettamente tramite il family trust 9.851 azioni, oltre ai nuovi premi azionari. La vendita delle azioni 猫 stata effettuata in pi霉 transazioni con una variazione di prezzo di $0,03.

Ian T. Clark, Director de Guardant Health, inform贸 m煤ltiples transacciones de valores los d铆as 17-18 de junio de 2025:

  • Dispuso de 6,672 acciones ordinarias a un precio promedio de $48.38 por acci贸n, provenientes del Thornton-Clark Family Trust
  • Recibi贸 una nueva concesi贸n de opciones sobre acciones por 6,833 acciones con un precio de ejercicio de $50.57, que se consolidan completamente el 18 de junio de 2025 o en la pr贸xima reuni贸n anual de accionistas
  • 翱迟辞谤驳贸 5,092 unidades de acciones restringidas (RSU) que se consolidan por completo el 18 de junio de 2025 o en la pr贸xima reuni贸n anual de accionistas

Tras estas transacciones, Clark mantiene 9,851 acciones indirectamente a trav茅s del fideicomiso familiar, adem谩s de las nuevas concesiones de capital. La venta de acciones se llev贸 a cabo en m煤ltiples transacciones dentro de un rango de precio de $0.03.

Guardant Health鞚� 鞚挫偓 Ian T. Clark臧� 2025雲� 6鞗� 17-18鞚检棎 鞐煬 歃濌秾 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟:

  • Thornton-Clark 臧�臁� 鞁犿儊鞚� 韱淀暣 氤挫湢頃� 氤错喌欤� 6,672欤�毳� 欤茧嫻 韽夑窢 $48.38鞐� 觳橂秳頃�
  • 頄夓偓臧赌瓴� $50.57鞚� 6,833欤�鞚� 鞁犼窚 鞀ろ啞鞓奠厴 攵赌鞐�, 2025雲� 6鞗� 18鞚� 霕愲姅 雼れ潓 鞐半 欤检＜齑濏殞鞐� 鞝勲秬 頄夓偓 臧�電�
  • 2025雲� 6鞗� 18鞚� 霕愲姅 雼れ潓 鞐半 欤检＜齑濏殞鞐� 鞝勲秬 旆摑霅橂姅 5,092 鞝滍暅 欤检嫕 雼渼(RSU) 攵赌鞐�

鞚� 瓯半灅霌� 鞚错泟 Clark鞚� 臧�臁� 鞁犿儊鞚� 韱淀暣 臧勳爲鞝侅溂搿� 9,851欤�毳� 氤挫湢頃橂┌, 鞁犼窚 欤检嫕 氤挫儊霃� 韽暔霅╇媹雼�. 欤检嫕 毵る弰電� $0.03 臧�瓴� 氩旍渼 雮� 鞐煬 瓯挫溂搿� 鞚措（鞏挫鞀惦媹雼�.

Ian T. Clark, directeur de Guardant Health, a d茅clar茅 plusieurs transactions sur titres les 17 et 18 juin 2025 :

  • A c茅d茅 6 672 actions ordinaires 脿 un prix moyen de 48,38 $ par action provenant du Thornton-Clark Family Trust
  • A re莽u une nouvelle attribution d'options d'achat portant sur 6 833 actions avec un prix d'exercice de 50,57 $, acquises en totalit茅 le 18 juin 2025 ou lors de la prochaine assembl茅e annuelle des actionnaires
  • A obtenu 5 092 unit茅s d'actions restreintes (RSU) acquises en totalit茅 le 18 juin 2025 ou lors de la prochaine assembl茅e annuelle des actionnaires

Apr猫s ces op茅rations, Clark d茅tient indirectement 9 851 actions via le family trust, en plus des nouvelles attributions d'actions. La vente des actions a 茅t茅 r茅alis茅e en plusieurs op茅rations dans une fourchette de prix de 0,03 $.

Ian T. Clark, Direktor von Guardant Health, meldete mehrere Wertpapiertransaktionen am 17. und 18. Juni 2025:

  • 痴别谤盲耻脽别谤迟别 6.672 Stammaktien zu einem Durchschnittspreis von 48,38 $ pro Aktie aus dem Thornton-Clark Family Trust
  • Erhielt eine neue Aktienoptionszuteilung f眉r 6.833 Aktien mit einem Aus眉bungspreis von 50,57 $, die vollst盲ndig am 18. Juni 2025 oder auf der n盲chsten j盲hrlichen Hauptversammlung der Aktion盲re f盲llig wird
  • Gew盲hrt wurden 5.092 Restricted Stock Units (RSUs), die ebenfalls am 18. Juni 2025 oder auf der n盲chsten j盲hrlichen Hauptversammlung vollst盲ndig freigegeben werden

Nach diesen Transaktionen h盲lt Clark indirekt 9.851 Aktien 眉ber den Family Trust sowie die neuen Aktienverg眉tungen. Der Aktienverkauf erfolgte in mehreren Transaktionen innerhalb einer Preisspanne von 0,03 $.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CLARK IAN T
(Last) (First) (Middle)
3100 HANOVER STREET
(Street)
PALO ALTO CA 94304
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/17/2025 S 6,672 D $48.3841(1) 9,851 I By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $50.57 06/18/2025 A 6,833 (2) 06/18/2035 Common Stock 6,833 $0 6,833 D
Restricted Stock Units $0 06/18/2025 A 5,092 (3) (4) Common Stock 5,092 $0 5,092 D
Explanation of Responses:
1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.38 to $48.41 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.
3. The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.
4. Not applicable for Restricted Stock Units.
Remarks:
/s/ John G. Saia, as attorney-in-fact for Ian T. Clark 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What insider trading activity occurred at Guardant Health (GH) on June 17, 2025?

Director Ian T. Clark sold 6,672 shares of GH common stock at a weighted average price of $48.3841 per share through The Thornton-Clark Family Trust. Following this transaction, the trust retained ownership of 9,851 shares.

What new stock options were granted to GH director Ian Clark in June 2025?

On June 18, 2025, Ian Clark was granted 6,833 stock options with an exercise price of $50.57. These options vest in full on the one-year anniversary of the grant date (June 18, 2025) or the date of the next annual stockholders meeting, whichever is earlier, and expire on June 18, 2035.

How many restricted stock units (RSUs) did GH director Ian Clark receive in June 2025?

Ian Clark received 5,092 restricted stock units on June 18, 2025. These RSUs vest in full on the one-year anniversary of the grant date (June 18, 2025) or the date of the next annual stockholders meeting, whichever is earlier.

What is the total value of GH shares sold by Ian Clark in the June 17, 2025 transaction?

Ian Clark sold 6,672 shares at a weighted average price of $48.3841, resulting in a total transaction value of approximately $322,800. The shares were sold in multiple transactions at prices ranging from $48.38 to $48.41 per share.
Stock GH logo
Guardant Health

NASDAQ:GH

GH Rankings

#1093 Ranked by Market Cap
N/A Ranked by Dividends

GH Latest News

Aug 15, 2025
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 4, 2025
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity
Jul 31, 2025
Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference
Jul 30, 2025
Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Jul 30, 2025
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+

GH Latest SEC Filings

Aug 6, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity
Aug 4, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity
Jul 30, 2025
[10-Q] Guardant Health, Inc. Quarterly Earnings Report
Jul 30, 2025
[8-K] Guardant Health, Inc. Reports Material Event
Jul 18, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity

GH Stock Data

7.30B
118.23M
4.5%
99.25%
7.7%
Diagnostics & Research
Services-medical Laboratories
United States
PALO ALTO